Ceylon Hospitals Plc Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

2,834.22

2,693.44

2,697.86

2,753.48

2,536.62

2,390.98

2,386.76

Other Operating Income

0.00

Total Operating income

2,834.22

2,693.44

2,697.86

2,753.48

2,536.62

2,390.98

2,386.76

Raw Material Cost

1,000.13

1,024.40

1,061.25

1,124.26

994.74

928.45

1,031.52

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

45.14

47.89

48.77

51.25

52.46

55.53

63.32

Selling and Distribution Expenses

1,216.46

1,098.01

1,087.50

1,024.61

982.93

928.24

921.76

Other Expenses

-4.51

-4.79

-4.88

-5.13

-5.25

-5.55

-6.33

Total Expenditure (Excl Depreciation)

2,216.59

2,122.41

2,148.76

2,148.87

1,977.67

1,856.68

1,953.28

Operating Profit (PBDIT) excl Other Income

617.6

571

549.0999999999999

604.6

559

534.3

433.5

Other Income

-231.21

-202.79

-180.03

-133.10

-254.32

14.86

-247.38

Operating Profit (PBDIT)

600.32

585.96

369.07

656.35

391.16

902.70

363.45

Interest

45.14

47.89

48.77

51.25

52.46

55.53

63.32

Exceptional Items

0.00

Gross Profit (PBDT)

1,834.09

1,669.04

1,636.61

1,629.22

1,541.88

1,462.54

1,355.24

Depreciation

213.89

217.72

0.00

184.84

86.53

353.54

177.35

Profit Before Tax

341.29

320.35

320.30

420.26

252.18

493.63

122.78

Tax

95.33

75.25

67.76

112.05

64.44

38.40

39.35

Provisions and contingencies

0.00

Profit After Tax

232.56

216.56

230.30

271.72

181.21

397.93

74.65

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

232.56

216.56

230.30

271.72

181.21

397.93

74.65

Share in Profit of Associates

0.00

Minority Interest

13.39

28.54

22.24

36.49

6.53

57.30

8.77

Other related items

0.00

Consolidated Net Profit

245.96

245.10

252.54

308.21

187.74

455.23

83.42

Equity Capital

0.00

Face Value

0.0

Reserves

11,888.84

11,661.59

11,445.03

11,214.34

11,110.21

9,069.24

8,659.16

Earnings per share (EPS)

1.39

1.29

1.37

1.62

1.08

2.42

0.45

Diluted Earnings per share

1.39

1.29

1.37

1.62

1.08

2.42

0.45

Operating Profit Margin (Excl OI)

21.79%

21.2%

20.35%

21.96%

22.04%

22.35%

18.16%

Gross Profit Margin

19.59%

19.98%

11.87%

21.98%

13.35%

35.43%

12.57%

PAT Margin

8.21%

8.04%

8.54%

9.87%

7.14%

16.64%

3.13%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is 5.23% vs -0.17% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 0.37% vs -2.93% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 5.43% vs 43.64% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is -5.85% vs -1.84% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Ceylon Hospitals Plc With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(LKR)

Change(%)

Net Sales

2,834.22

3,438.43

-604.21

-17.57%

Other Operating Income

0.00

Total Operating income

2,834.22

3,438.43

-604.21

-17.57%

Raw Material Cost

1,000.13

2,057.42

-1,057.29

-51.39%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

578.87

-578.87

-100.00%

Power Cost

0.00

Manufacturing Expenses

45.14

208.12

-162.98

-78.31%

Selling and Distribution Expenses

1,216.46

828.82

387.64

46.77%

Other Expenses

-4.51

-78.70

74.19

94.27%

Total Expenditure (Excl Depreciation)

2,216.59

2,886.24

-669.65

-23.20%

Operating Profit (PBDIT) excl Other Income

617.63

552.18

65.45

11.85%

Other Income

-231.21

4.80

-236.01

-4,916.88%

Operating Profit (PBDIT)

600.32

852.24

-251.92

-29.56%

Interest

45.14

208.12

-162.98

-78.31%

Exceptional Items

0.00

Gross Profit (PBDT)

1,834.09

1,381.00

453.09

32.81%

Depreciation

213.89

295.25

-81.36

-27.56%

Profit Before Tax

341.29

348.87

-7.58

-2.17%

Tax

95.33

209.22

-113.89

-54.44%

Provisions and contingencies

0.00

Profit After Tax

232.56

139.65

92.91

66.53%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

232.56

139.65

92.91

66.53%

Share in Profit of Associates

0.00

Minority Interest

13.39

0.00

13.39

Other related items

0.00

Consolidated Net Profit

245.96

139.65

106.31

76.13%

Equity Capital

0.00

Face Value

0.00

Reserves

11,888.84

6,081.49

5,807.35

95.49%

Earnings per share (EPS)

1.39

0.10

1.29

1,290.00%

Diluted Earnings per share

1.39

0.10

1.29

1,290.00%

Operating Profit Margin (Excl OI)

21.79%

16.06%

0.00

5.73%

Gross Profit Margin

19.59%

18.73%

0.00

0.86%

PAT Margin

8.21%

4.06%

0.00

4.15%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 283.42 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 5.23% vs -0.17% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 11.73% vs 7.42% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 24.60 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 0.37% vs -2.93% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 31.06% vs -14.53% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 83.15 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 5.43% vs 43.64% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 28.81% vs -13.06% in Mar 2025

Quarterly - Interest

Interest 4.51 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -5.85% vs -1.84% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -14.10% vs 54.87% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 21.79%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025